mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.1 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.1 |